
Rabinose D 30mg/40mg Capsule SR
Marketer
Nanos Medicare Pvt. Ltd.
Salt Composition
Domperidone (30mg) + Rabeprazole (40mg)
Overview Rabinose D 30mg/40mg Capsule SR
Gastro-esophageal reflux disease (GERD), or acid reflux, can be managed with the dual-action formulation, Rabinose D 30mg/40mg SR Capsules. This medication targets acid reflux symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion for improved comfort. Dosage and duration of Rabinose D 30mg/40mg SR Capsules should strictly adhere to your physician's instructions, depending on individual response and condition severity. Premature discontinuation may lead to symptom recurrence and disease exacerbation. Complete transparency with your healthcare provider regarding all concurrent medications is crucial due to potential interactions. Common, typically transient side effects include diarrhea, abdominal discomfort, dry mouth, headache, flatulence, and fatigue. Report any concerning side effects immediately. Drowsiness and dizziness are possible; therefore, avoid activities requiring alertness until the medication's effects are known. Alcohol consumption should be avoided as it can intensify drowsiness. Lifestyle adjustments, such as consuming cold milk and eliminating hot beverages, spicy foods, and chocolate, can enhance treatment outcomes. Prior to commencing treatment, disclose any pre-existing liver or kidney conditions, pregnancy, pregnancy planning, or breastfeeding to your doctor.
Uses of Rabinose D 30mg/40mg Capsule SR
Managing acid reflux and peptic ulcers.
Major Benefits of Rabinose D 30mg/40mg Capsule SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the entire capsule without chewing, crushing, or fracturing. Rabinose D 30mg/40mg Sustained-Release Capsules should be administered on an empty stomach.
Common Side effects of Rabinose D 30mg/40mg Capsule SR:
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Nasal congestion (stuffy nose)
- Insomnia (difficulty in sleeping)
- Fundic gland polyps
- Nausea
- Constipation
- Flatulence
- Back pain
- Pharyngitis
How to use Rabinose D 30mg/40mg Capsule SR:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the entire capsule without chewing, crushing, or breaking it. Rabinose D 30mg/40mg sustained-release capsules should be taken on an empty stomach.
How Rabinose D 30mg/40mg Capsule SR works:
Rabinose D SR capsules (30mg/40mg Domperidone/Rabeprazole) combine a prokinetic agent, Domperidone, with a proton pump inhibitor (PPI), Rabeprazole. Domperidone enhances upper gastrointestinal motility, facilitating smoother food passage. Rabeprazole diminishes stomach acid production, providing relief from acid indigestion and heartburn symptoms.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Rabinose D 30mg/40mg sustained-release capsules with alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Rabinose D 30mg/40mg sustained-release capsules during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks before recommending this medication. Medical advice is essential.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Rabinose D 30mg/40mg capsule is likely not safe for use while breastfeeding. Available human data indicates potential transfer to breast milk with possible infant harm.
DrivingUNSAFE
Taking Rabinose D 30mg/40mg sustained-release capsules may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Renal impairment necessitates careful use and potential dosage modification of Rabinose D 30mg/40mg sustained-release capsules. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Rabinose D 30mg/40mg SR capsules cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Rabinose D 30mg/40mg SR capsules are contraindicated in individuals with moderate to severe hepatic dysfunction.
What if you forget to take Rabinose D 30mg/40mg Capsule SR :
Should you forget a dose of Rabinose D 30mg/40mg sustained-release capsules, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rabinose D 30mg/40mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
